hi mate; just airing a couple of thoughts for the heck of it;
Mr Fraser, imo, was a huge draw card, that and the progress of the vaccs, severely knocked on the head with the failure to partner up, even a modest Mr Fraser said he was ‘lucky’ in his breakthrough, with team, with his previous work.
the CardioCel, seemingly the ‘cream’ on top of the cake at the time.
your other comments certainly highlight the high risks involved, that said, that to highlight those risks then referred to as ‘running down the company’!, lol, can’t have it both ways can we?, say high risk but neglect to mention the risks.
last para, ref; management team and shares; they hardly have much choice do they,?, if done ages back it might have helped the cause a little.
also as ugly as it is, is the list of options sp, most unlikely to be ever exercised, rather sobering is the thought that it is a graphic display of the fortunes of this company, imo, that without even taking into account the huge share dilution in that period of time.
it would be hoped that a announcement will arrive before Sept 30 th, as in a game changing announcement to the benefit of RIs, if not, it certainly should be a concern, no luxury of available funds to ride out this impasse out while the deal negotiations continue.
Expand
